Seattle, WA, United States of America

Michael R Comeau


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1998-2007

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Michael R. Comeau

Introduction

Michael R. Comeau is a prominent inventor based in Seattle, WA. He holds a total of seven patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on viral encoded semaphorin protein receptor DNA and polypeptides, which have important implications in medical research and treatment.

Latest Patents

Among his latest patents is the invention of Viral Encoded Semaphorin Protein Receptor DNA and Polypeptides. This invention is directed to VESPR polypeptides as a purified and isolated protein, the DNA encoding the VESPR polypeptide, host cells transfected with cDNAs encoding VESPR, and methods for preparing VESPR polypeptides. Another notable patent is for Antibodies to Viral Encoded Semaphorin Protein Receptor Polypeptides, which also focuses on VESPR polypeptides and their applications in various medical fields.

Career Highlights

Michael R. Comeau has made significant strides in his career, particularly through his work at Immunex Corporation. His innovative research has led to advancements in understanding viral interactions and potential therapeutic applications. His expertise in the field has positioned him as a key figure in biotechnology.

Collaborations

Michael has collaborated with notable colleagues, including Melanie K. Spriggs and Robert F. DuBose. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Michael R. Comeau's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…